GU Cancers 2023 | Advances in PSMA-targeted therapy for prostate cancer

David M. Nanus, MD, Weill Cornell Medicine and New York Presbyterian Hospital, New York City, NY, discusses recent advances in PSMA-targeted therapies for patients wiith prostate cancer, such as radiopharmaceuticals. Dr Nanus also talks on the crucial role of PSMA PET scans in these situations. This interview took place at the ASCO GU Cancers Symposium 2023 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.